Latest research
Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Top papers this month · This week's roundup
Trending topics
Meta-analysis of 53 studies (1,402,868 young people, 58 countries): 76.5% of children and 54.8% of adolescents met sleep duration recommendations; the adolescent difference was not significant after multiplicity adjustment. Prevalence was lower on school days.
Meta-analysisn = 1,402,868
Ezzatvar et al. Prevalence of meeting sleep duration recommendations among over 1.4 million children and adolescents across 58 countries: a systematic review and meta-analysisMeta-analysis of 123 studies (1 052 445 adults with hypertension): estimated pooled global adherence to antihypertensives was 58% (95% CI 52%-63%), ranging from 67% in Europe to 45% in North America; only age and assessment tool were significant moderators.
Meta-analysisn = 1,052,445
Ngolombe et al. Global Prevalence of Adherence to Antihypertensives and Associated Moderating Factors Among Adults With Hypertension: A Meta-AnalysisSystematic review and meta-analysis of 51 studies (34,623 patients) after stopping anticoagulation for VTE: APS, antithrombin deficiency, homozygous FVL and compound FVL/PTM were associated with roughly 2–3-fold recurrence risk; heterozygous FVL or PTM about 1.5-fold.
Meta-analysisn = 34,623
Vrotniakaite-Bajerciene et al. Recurrent VTE in patients with thrombophilia after stopping anticoagulation: a systematic review and meta-analysisIn an individual participant data meta-analysis of 13,851 adults, worsening hearing loss was associated with higher all-cause mortality (HR 1·19–1·56) and hearing-aid use with lower mortality (HR 0·91); replicated in 50,277 Norwegian adults.
Meta-analysisn = 13,851
Li et al. Hearing loss, hearing-aid use, and mortality risk: individual participant data meta-analysis of population-based studies from Australia, Iceland, and the USA and a replication study from NorwayIn a meta-analysis of 58 studies (13,530 patients) with acquired hypofibrinogenaemia, adults given fibrinogen concentrate received fewer red cell (IRR 0.72), plasma (IRR 0.69) and platelet units (IRR 0.56) than with other treatments, largely driven by cardiac surgery studies.
Meta-analysisn = 13,530
Rahe-Meyer et al. The role of fibrinogen concentrate in the reduction of allogeneic blood product requirements: a systematic review and meta-analysisIn 4000 Thai adults after a two-dose COVID-19 primary series, a single HXP-GPOVac booster met non-inferiority to VAXZEVRIA for day-14 neutralising antibodies (GMC ratio 0.83; seroconversion difference −2.35%); solicited AEs 43.7% vs 53.5%.
RCTn = 4,000
Prasert et al. Safety and immunogenicity of Thailand Government Pharmaceutical Organization (GPO) produced, COVID-19 vaccine, 10 μg HXP-GPOVac: A Phase III, double-blind, randomized trial in comparison with VAXZEVRIAMeta-analysis of 4 RCTs (2,651 patients) with STEMI and multivessel disease: immediate vs staged complete revascularisation had higher 1-year all-cause death (HR 1.50) and fewer protocol-defined MIs but not spontaneous MIs; the mortality finding is fragile.
Meta-analysisn = 2,651
O'Callaghan et al. Immediate Versus Staged Complete Revascularization in Multivessel Disease and STEMI: A Meta-Analysis of Randomized TrialsIn 989 children and adults bleeding during cardiac surgery with bypass, platelets cold-stored up to 21 days were noninferior to room-temperature platelets on a haemostatic efficacy score (mean difference 0.09); reexploration rates were higher with cold-stored platelets.
RCTn = 1,000
Spinella et al. Cold and Room-Temperature Platelets in Cardiac Surgery: The CHIPS Randomized Clinical TrialSystematic review of 12 studies (9 meta-analysed, 822 participants) in psychotic disorders found no general association between basal cortisol and cognition; higher afternoon/evening cortisol was linked to poorer executive functioning (r = -0.27).
Meta-analysisn = 940
Chen et al. Cortisol and cognition in psychotic disorders: A systematic review and multi-level meta-analysisIn 825 evaluable women with breast reconstruction needing postmastectomy radiotherapy, 16-fraction hypofractionated RT was non-inferior to 25-fraction RT for 24-month reconstruction complications (12.3% vs 10.2%; difference -2.1%, 95% CI -6.5 to 2.2).
RCTn = 898
Poppe et al. Randomized Trial of Hypofractionated Postmastectomy Radiation Therapy in Women With Breast Reconstruction (RT CHARM, Alliance A221505)